Strata Critical Medical, Inc. (SRTA) — Cash Flow-to-Debt Ratio
Strata Critical Medical, Inc. (SRTA) has a Cash Flow-to-Debt Ratio of -0.61x as of September 2025, meaning its operating cash flow of $-31.84 Million could theoretically repay -1% of its total liabilities ($52.08 Million) in one year. See Strata Critical Medical, Inc. free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Strata Critical Medical, Inc. Cash Flow-to-Debt Ratio (2019–2024)
Historical debt coverage capacity for Strata Critical Medical, Inc. across 6 annual periods. Also explore Strata Critical Medical, Inc. annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Strata Critical Medical, Inc. (2019–2024)
Year-by-year debt coverage analysis for Strata Critical Medical, Inc.. For market capitalisation and broader financial context, see Strata Critical Medical, Inc. stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.07x | $-2.52 Million | $34.74 Million | ▲ +86.4% |
| 2023 | -0.53x | $-32.35 Million | $60.64 Million | ▲ +27.4% |
| 2022 | -0.73x | $-37.13 Million | $50.54 Million | ▼ -109.4% |
| 2021 | -0.35x | $-15.62 Million | $44.51 Million | ▲ +78.5% |
| 2020 | -1.63x | $-10.82 Million | $6.63 Million | ▼ -4215.8% |
| 2019 | -0.04x | $-10.30 Million | $272.69 Million | — |